Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. JNJ
JNJ logo

JNJ

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

JNJ News

Johnson & Johnson Q1 2026 Earnings Beat Expectations but Stock Declines

1d agoNASDAQ.COM

Intuitive Surgical Reports Continued Growth Amid Rising Competition

2h agoNASDAQ.COM

Intuitive Surgical: Leader in Robotic Surgery Market

3h agoFool

Johnson & Johnson's Stock Pullback Amid Strong Momentum

1d agoFool

Teva's FDA Approval of Long-Acting Drug Could Be Major Catalyst

1d agoNASDAQ.COM

Teva Pharmaceutical Shares Surge 130% with Optimistic Outlook

1d agoFool

U.S. Judge Denies Bayer's Bid for Injunction Against Johnson & Johnson's Alleged Misstatements Regarding Prostate Cancer Medication

1d agomoomoo

Jim Cramer Updates Bullpen Watchlist with New Stocks

2d agoCNBC

Three Biotech Companies Worth Watching

2d agoNASDAQ.COM

Three Biotech Stocks Worth Watching

2d agoFool

Dividend King Johnson & Johnson Sees Strong Growth

2d agoFool

Johnson & Johnson Stock Analysis: Strong Growth Ahead

2d agoNASDAQ.COM

CNBC Investing Club April Meeting Highlights

2d agoCNBC

Healthcare Stocks Resilient During Economic Downturns

3d agoFool

MeiraGTx Prices $100M Equity Offering to Acquire Gene Therapy bota-vec

3d agoseekingalpha

Structural Shift in U.S. Heart Care Market

3d agoNewsfilter